Intercure LTD

Schedule 13D - Activist Investments

NASDAQ

9 Dec 2025

INCR

SCHEDULE: InterCure CEO Boosts Stake to 29.4% via Private Placement

InterCure Ltd.'s CEO, Alexander Rabinovich, increased his beneficial ownership to 29.4% through a private placement and warrant acquisition, reinforcing his control.

Capital raise